Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00085397 · UNKNOWN

Trial details

NCT number: NCT00085397
Sponsor: Dana-Farber Cancer Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2004-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.